3791-3800 of 4404 results
The devil in the detail - observations on the scope of CDR data and the new Privacy Safeguards
While the Consumer Data Right CDR regime is likely to benefit businesses by increasing access to greater consumer data and customers by increasing choice and competition the draft legislation leaves a lot of the details to be finalised at a later date primarily through the Australian Competition and ...
Risky business - remedies and enforcement powers for CDR breaches
As part of the new Consumer Data Right CDR framework a new regime of offences remedies and enforcement powers will be implemented The Australian Competition and Consumer Commission ACCC will have primary oversight for the enforcement of the regime though the OAIC will handle privacy complaints in ...
Measuring ‘spilt milk’
Can food and beverage industry participants be found to have engaged in misleading or deceptive conduct for failure to comply with aspects of relevant regulatory regimes? The Federal Court has confirmed that they can. ...
A pattern of infringement
The recent decision in The Dempsey Group Pty Ltd v Spotlight Pty Ltd [2018] FCA 2016 on what constitutes the reproduction of a substantial part of a copyright work offers a timely reminder for Australian textile merchants on how best to thread the needle when purchasing designs from third-party manu ...
Fairfax says it's the BOSS
Network 10 has recently undergone a rebrand, with new channel names and logos. However, this was not without controversy, after Fairfax Media raised concerns about potential trade mark infringement. ...
ASIC extends transition period for fees and costs disclosures, and delays consultation paper to January 2019
ASIC has extended the transition periods for certain fees and costs disclosure obligations applicable to superannuation funds and managed investment schemes by a further year pending the release of its consultation paper on the regime ...
Protecting innovation without patents - data exclusivity and market exclusivity
Developments in patent law and the consequential limitations on patentability for biologic medicines mean that data exclusivity and market exclusivity can be the primary protection afforded to originator biologic medicines This is most stark in the US where patent protection for biologic medicines ...
Report: Allens' response to ACL Review Interim Report
Allens submission in response to the Australian Consumer Law Review Interim Report Although the Australian Consumer Law is generally functioning well Allens considers that a number of provisions require amendment and clarification to ensure that the ACL meets its objectives ...
Significant changes ahead for Australian competition laws
The Federal Governments Competition Policy Bill which contains its response to the Harper Reviews broader recommendations on competition law and policy will make significant changes to Australian competition laws ...
The CoOL change is here
We provide an update on the new Country of Origin Labelling regime which came into effect on 1 July 2016 and the Federal Government’s proposed changes to the safe harbour provisions under the Australian Consumer Law. ...


